当前位置: »论坛 › 科研专区 › 文献互助› Phase 2 Trial of Intravesical Gemcitabine and Doceta ...

[ovid] Phase 2 Trial of Intravesical Gemcitabine and Docetaxel as First-Line Treatment of Bacillus Calmette-Guérin-Naive Nonmuscle-Invasive Urothelial Carcinoma: Updated, 3-Year Outcomes

lllmed2024 发表于 2 小时前 | 显示全部楼层 |阅读模式

此帖将于 2026-10-25 04:52 自动关闭

悬赏10积分

期刊：Journal of Urology

文献作者：Tyler S. Garman; Soum Lokeshwar; Jack Campbell; Zhuo Tony Su; Andrew T. Gabrielson; Nirmish Singla; Bruce J. Trock; Trinity J. Bivalacqua; Sunil H. Patel; Max R. Kates

出版日期：2026-10-

DOI号：10.1097/ju.0000000000005179

下载链接：http://www.auajournals.org/doi/pdf/10.1097/JU.0000000000005179

文献链接：https://doi.org/10.1097/ju.0000000000005179

当前文献来源于 Ovid Technologies (Wolters Kluwer Health)。

备注信息：

使用道具捐赠获取积分应助有误反馈

全部回复0 显示全部楼层

发表回复

lllmed2024 Lv.2

注册会员

发布
回复
积分
30

[ovid] Phase 2 Trial of Intravesical Gemcitabine and Docetaxel as First-Line Treatment of Bacillus Calmette-Guérin-Naive Nonmuscle-Invasive Urothelial Carcinoma: Updated, 3-Year Outcomes

发表回复

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[ovid] Phase 2 Trial of Intravesical Gemcitabine and Docetaxel as First-Line Treatment of Bacillus Calmette-Guérin-Naive Nonmuscle-Invasive Urothelial Carcinoma: Updated, 3-Year Outcomes 一键复制

发表回复

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[ovid] Phase 2 Trial of Intravesical Gemcitabine and Docetaxel as First-Line Treatment of Bacillus Calmette-Guérin-Naive Nonmuscle-Invasive Urothelial Carcinoma: Updated, 3-Year Outcomes